SECAUCUS, N.J., July 17, 2018 /PRNewswire/ --
2018 QUEST DIAGNOSTICS STUDY FINDS:
A new study of physicians and health plan executives suggests that progress toward value-based care has stalled, and it may have even taken a step backward over the past year. The study, commissioned by Quest Diagnostics (NYSE: DGX), points to physicians' lack of tools and insufficient information about their patients as possible reasons. Other barriers include continuing misalignment of perceptions of physicians and health plan executives, particularly regarding the usefulness of quality metrics and technology in providing patient care.
"Stalled Progress on the Path to Value-Based Care" is the third annual study from Quest Diagnostics to gauge perceptions of physicians and health plan executives about the nation's journey to value-based healthcare, which focuses on care quality and patient outcomes rather than the quantity of services delivered.
To view the study, click here.
The study analyzes results from a survey of 451 primary care physicians and health plan executives collected earlier this year. It also reveals changes in perceptions over the past two years.
Key findings:
The survey also revealed differing perceptions of the usefulness of consumer-based strategies and investments in new technologies versus existing technologies in advancing value-based care.
"While our study suggests the healthcare industry still has a long way to go to deliver value-based care, it reveals avenues to speed the journey," said L. Patrick James, M.D., chief clinical officer, health plans and policy, medical affairs, Quest Diagnostics. "Measures that optimize EHRs, make data more accessible and insightful and reduce complexity of quality measurement are much needed steps to accelerate this transition. First, however, it's clear that health plan executives and physicians need to better align around a shared vision of how technology and data can improve patient care."
"It's encouraging to see that physicians and health plan executives recognize the potential of emerging technologies, such as artificial intelligence and blockchain in healthcare, to catalyze the shift to value-based care," said Lidia Fonseca, senior vice president and chief information officer, Quest Diagnostics. "That's a positive sign because it means our industry may be more open to harnessing the power of technology and insights from data to spur important transitions – like the shift to value-based care – than it was just a few years ago."
The study, "Stalled Progress on the Path to Value-Based Care," can be downloaded here.
To download the 2017 study, "Progress on the Path to Value-Based Care," click here.
To download the 2016 study, "Finding a Faster Path to Value-Based Care," click here.
Methodology
Regina Corso Consulting conducted an online survey on behalf of Quest Diagnostics from April 26-May 7, 2018. The survey was conducted among 451 respondents. Of these, 300 were primary care physicians employed in a private practice but who have an affiliation with a hospital and 151 were health plan executives (director-level and above). The margin of error for the full sample was +/- 5 percent.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.
The company's Quanum™ portfolio of data analytics and information technology solutions leverages Quest's national connectivity, big data, technology and clinical expertise to help improve quality, outcomes, patient engagement and financial performance. For more information, visit QuanumSuite.QuestDiagnostics.com/Quanum.
SOURCE Quest Diagnostics